Auto giant Stellantis suspends full-year guidance due to uncertainties over Trump tariffs

Auto giant Stellantis suspends full-year guidance due to uncertainties over Trump tariffs


Stellantis logo is pictured at one of its assembly plants following a company’s announcement saying it will pause production there, in Toluca, state of Mexico, Mexico, on April 4, 2025.

Henry Romero | Reuters

Auto giant Stellantis on Wednesday said it was withdrawing its full-year financial guidance due to uncertainties regarding the impact of U.S. President Donald Trump’s back-and-forth trade policy.

The multinational conglomerate, which owns household names including Jeep, Dodge, Fiat, Chrysler and Peugeot, reported first-quarter net revenues of 35.8 billion euros ($40.7 billion), reflecting a 14% drop from the previous year.

The company said the decline in net revenues was primarily due to lower shipment volumes, an adverse regional mix and price normalization.

This is breaking news. Please refresh for updates.



Source

H-1B visa applicants face more disruptions amid social media checks and wage protection rules
World

H-1B visa applicants face more disruptions amid social media checks and wage protection rules

H-1B applicants face a challenging year ahead as political pushback to the visas is reinforced with a slew of actions from the U.S. administration. On Monday, the U.S. Embassy in India posted on X that since Dec. 15, it has started conducting online presence reviews of all H-1B and H-4 visa applicants in a bid […]

Read More
What a Russia-Ukraine peace deal could mean for Europe’s gas supplies
World

What a Russia-Ukraine peace deal could mean for Europe’s gas supplies

Europe is pressing ahead with plans to ban Russian gas imports by the end of 2027, effectively capping Moscow’s energy future in the region and leaving a bevy of stranded assets in its wake. The dual Nord Stream 1 and 2 subsea pipelines were early casualties of Russia’s invasion of Ukraine, with the infrastructure being […]

Read More
Shares in Wegovy-maker Novo Nordisk pop 6% after GLP-1 pill approval
World

Shares in Wegovy-maker Novo Nordisk pop 6% after GLP-1 pill approval

Shares in Novo Nordisk surged 6% Monday, after the Wegovy maker secured approval of its GLP-1 pill — a world first. The U.S. Food and Drug Administration’s approval of Novo Nordisk’s GLP-1 pill gives the Danish pharmaceutical giant a head start over U.S. rival Eli Lilly. The pill’s starting dose of 1.5 milligrams will be […]

Read More